135 related articles for article (PubMed ID: 3117973)
1. Uptake of L-threo-dihydroxyphenylserine into human brain synaptosomes.
Naoi M; Nagatsu T
J Neural Transm; 1987; 70(1-2):51-61. PubMed ID: 3117973
[TBL] [Abstract][Full Text] [Related]
2. [Synthesis of norepinephrine from 3,4-dihydroxyphenylserine by L-aromatic amino acid decarboxylase of the rat brain and kidneys].
Fujiwara H; Inagaki C; Ikeda Y; Tanaka C
Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):891-8. PubMed ID: 14060
[TBL] [Abstract][Full Text] [Related]
3. [Inhibition of harmaline induced tremor by L-threo-3, 4-dihydroxyphenylserine, an L-norepinephrine precursor].
Yamazaki M; Ikeda Y; Ishikawa M; Inagaki C; Tanaka C
Nihon Yakurigaku Zasshi; 1976 Apr; 72(3):363-9. PubMed ID: 986992
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat heart.
Ohmura I; Inagaki C; Araki H; Tanaka C
Jpn J Pharmacol; 1978 Oct; 28(5):747-53. PubMed ID: 31501
[TBL] [Abstract][Full Text] [Related]
5. L-threo-3,4-dihydroxyphenylserine (DOPS) aldolase: a new enzyme cleaving DOPS into protocatechualdehyde and glycine.
Naoi M; Takahashi T; Kuno N; Nagatsu T
Biochem Biophys Res Commun; 1987 Mar; 143(2):482-8. PubMed ID: 3105531
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of monoamine oxidase by 3,4-dihydroxyphenylserine.
Naoi M; Nagatsu T
J Neurochem; 1986 Aug; 47(2):604-7. PubMed ID: 3090204
[TBL] [Abstract][Full Text] [Related]
7. Studies on the activity of L-threo-3,4-dihydroxyphenylserine (L-DOPS) as a catecholamine precursor in the brain. Comparison with that of L-dopa.
Kato T; Karai N; Katsuyama M; Nakamura M; Katsube J
Biochem Pharmacol; 1987 Sep; 36(18):3051-7. PubMed ID: 3115271
[TBL] [Abstract][Full Text] [Related]
8. Effect of L-threo-3,4-dihydroxyphenylserine(L-threo-DOPS) on brain and serum MHPG levels in mice: evidence for NE formation in CNS.
Karai N; Kato T; Katsuyama M; Nakamura M; Katsube J
Life Sci; 1987 Jun; 40(23):2261-8. PubMed ID: 3108598
[TBL] [Abstract][Full Text] [Related]
9. Effective treatment of pure akinesia with L-threo-3,4-dihydroxyphenylserine (DOPS): report of a case, with pharmacological considerations.
Yamamoto M; Ujike H; Ogawa N
Clin Neuropharmacol; 1985; 8(4):334-42. PubMed ID: 2416437
[TBL] [Abstract][Full Text] [Related]
10. L-threo-3, 4-dihydroxyphenylserine treatment of Parkinson's disease.
Ogawa N; Yamamoto M; Takayama H
J Med; 1985; 16(5-6):525-34. PubMed ID: 3938472
[TBL] [Abstract][Full Text] [Related]
11. The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine.
Bartholini J; Constantinidis J; Puig M; Tissot R; Pletscher A
J Pharmacol Exp Ther; 1975 May; 193(2):523-32. PubMed ID: 1142103
[TBL] [Abstract][Full Text] [Related]
12. Treatment of parkinsonism with L-threo-3,4-dihydroxyphenylserine: a pharmacokinetic study.
Suzuki T; Sakoda S; Ueji M; Kishimoto S; Hayashi A; Kondo T; Narabayashi H
Neurology; 1984 Nov; 34(11):1446-50. PubMed ID: 6436731
[TBL] [Abstract][Full Text] [Related]
13. Diuretic effects of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) in anesthetized rats.
Morimoto S; Matsumura Y; Ohyama T; Shinyama H; Ichihara T; Takahashi Y; Hisaki K
Jpn J Pharmacol; 1990 Mar; 52(3):431-9. PubMed ID: 2110272
[TBL] [Abstract][Full Text] [Related]
14. Effect of L-threo-3,4-dihydroxyphenylserine chronic administration on cerebrospinal fluid and plasma free 3-methoxy-4-hydroxy-phenylglycol concentration in patients with Parkinson's disease.
Yamamoto M; Ogawa N; Ujike H
J Neurol Sci; 1986 Mar; 73(1):39-44. PubMed ID: 3084714
[TBL] [Abstract][Full Text] [Related]
15. Effects of L-threo-3,4-dihydroxyphenylserine on efflux of monoamines and acetylcholine in guinea pig brain.
Nishino N; Fujii Y; Kondo M; Shuntoh H; Fujiwara H; Tanaka C
J Pharmacol Exp Ther; 1987 Aug; 242(2):621-8. PubMed ID: 3112367
[TBL] [Abstract][Full Text] [Related]
16. A new metabolic pathway of L-threo-3,4-dihydroxyphenylserine, a precursor amino acid of norepinephrine, in the brain. Studies by in vivo microdialysis.
Maruyama W; Nakahara D; Naoi M
J Neural Transm Park Dis Dement Sect; 1994; 7(1):21-33. PubMed ID: 8579767
[TBL] [Abstract][Full Text] [Related]
17. DL-threo-DOPS as a precursor of noradrenaline.
Reches A; Jackson-Lewis V; Fahn S
Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):202-8. PubMed ID: 3937060
[TBL] [Abstract][Full Text] [Related]
18. Catecholamine metabolism during additional administration of DL-threo-3,4-dihydroxyphenylserine to patients with Parkinson's disease.
Teelken AW; van den Berg GA; Muskiet FA; Staal-Schreinemachers AL; Wolthers BG; Lakke JP
J Neural Transm Park Dis Dement Sect; 1989; 1(3):177-88. PubMed ID: 2476157
[TBL] [Abstract][Full Text] [Related]
19. Effect of DL-erythro-dihydroxyphenylserine on the locomotor activity of the mouse.
Mori T; Nakajima T; Hashimoto H; Noto T; Kato N
Pharmacol Biochem Behav; 1985 Jun; 22(6):979-83. PubMed ID: 2862644
[TBL] [Abstract][Full Text] [Related]
20. Reversal by L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS), a L-norepinephrine precursor of reserpine- or tetrabenazine-induced hypothermia.
Katsuyama M; Kato T; Karai N; Nakamura M; Katsube J
Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):61-70. PubMed ID: 3099671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
